DK3867244T3 - 4-pyrazin-2-ylmethylmorfolinderivater og anvendelse deraf som lægemiddel - Google Patents
4-pyrazin-2-ylmethylmorfolinderivater og anvendelse deraf som lægemiddel Download PDFInfo
- Publication number
- DK3867244T3 DK3867244T3 DK19786343.4T DK19786343T DK3867244T3 DK 3867244 T3 DK3867244 T3 DK 3867244T3 DK 19786343 T DK19786343 T DK 19786343T DK 3867244 T3 DK3867244 T3 DK 3867244T3
- Authority
- DK
- Denmark
- Prior art keywords
- ylmethylmorpholine
- pyrazin
- medicine
- derivatives
- ylmethylmorpholine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18200943 | 2018-10-17 | ||
| PCT/EP2019/078027 WO2020079039A1 (en) | 2018-10-17 | 2019-10-16 | 4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3867244T3 true DK3867244T3 (da) | 2023-05-01 |
Family
ID=63878518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19786343.4T DK3867244T3 (da) | 2018-10-17 | 2019-10-16 | 4-pyrazin-2-ylmethylmorfolinderivater og anvendelse deraf som lægemiddel |
Country Status (38)
| Country | Link |
|---|---|
| US (3) | US11166958B2 (da) |
| EP (1) | EP3867244B1 (da) |
| JP (1) | JP7093468B2 (da) |
| KR (1) | KR102840105B1 (da) |
| CN (1) | CN112888685B (da) |
| AR (1) | AR116711A1 (da) |
| AU (1) | AU2019362330B2 (da) |
| BR (1) | BR112021004993A2 (da) |
| CA (1) | CA3113308A1 (da) |
| CL (1) | CL2021000858A1 (da) |
| CO (1) | CO2021004612A2 (da) |
| CR (1) | CR20210184A (da) |
| DK (1) | DK3867244T3 (da) |
| DO (1) | DOP2021000069A (da) |
| EA (1) | EA202191014A1 (da) |
| EC (1) | ECSP21027009A (da) |
| ES (1) | ES2940184T3 (da) |
| FI (1) | FI3867244T3 (da) |
| HR (1) | HRP20230249T1 (da) |
| HU (1) | HUE061891T2 (da) |
| IL (1) | IL282142B2 (da) |
| JO (1) | JOP20210075A1 (da) |
| LT (1) | LT3867244T (da) |
| MA (1) | MA53898B1 (da) |
| MX (1) | MX2021004418A (da) |
| MY (1) | MY205127A (da) |
| NZ (1) | NZ773672A (da) |
| PE (1) | PE20211278A1 (da) |
| PH (1) | PH12021550834A1 (da) |
| PL (1) | PL3867244T3 (da) |
| PT (1) | PT3867244T (da) |
| RS (1) | RS63988B1 (da) |
| SA (1) | SA521421756B1 (da) |
| SG (1) | SG11202103806VA (da) |
| SI (1) | SI3867244T1 (da) |
| TW (1) | TWI828779B (da) |
| UA (1) | UA128408C2 (da) |
| WO (1) | WO2020079039A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7318015B2 (ja) * | 2019-06-04 | 2023-07-31 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 特に抑うつ病性障害の処置のための、ｎｒ２ｂネガティブ調節剤としてのプリン誘導体および医薬としてのその使用 |
| WO2025233259A1 (en) | 2024-05-07 | 2025-11-13 | Boehringer Ingelheim International Gmbh | Compound for use in the treatment of depression, obsessive-compulsive disorder, post-traumatic stress disorder and/or borderline personality disorder |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6495561B2 (en) | 1999-10-29 | 2002-12-17 | Merck & Co., Inc. | 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists |
| AU2002338334B8 (en) | 2001-04-03 | 2008-09-18 | Merck & Co., Inc. | N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B antagonists |
| SI1409477T1 (sl) | 2001-07-24 | 2009-02-28 | Richter Gedeon Nyrt | Derivati piperidina kot antagonisti nmda-receptorjev |
| JP2009518409A (ja) * | 2005-12-06 | 2009-05-07 | メルク エンド カムパニー インコーポレーテッド | モルホリンカルボキサミドプロキネチシン受容体アンタゴニスト |
| WO2010088414A2 (en) * | 2009-01-28 | 2010-08-05 | Emory University | Subunit selective nmda receptor potentiators for the treatment of neurological conditions |
| WO2012128582A2 (en) | 2011-03-23 | 2012-09-27 | Hyundai Pharm Co., Ltd. | A COMPOUND FOR INHIBITING HUMAN 11-β-HYDROXY STEROID DEHYDROGENASE TYPE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME |
| UA114529C2 (uk) * | 2012-10-18 | 2017-06-26 | Ф. Хоффманн-Ля Рош Аг | Похідні етинілу як модулятори активності рецептора mglur5 |
| WO2015130905A1 (en) | 2014-02-27 | 2015-09-03 | Merck Patent Gmbh | Heterocyclic compounds as nav channel inhibitors and uses thereof |
| US10913736B2 (en) | 2014-08-22 | 2021-02-09 | University Of Washington | Specific inhibitors of methionyl-tRNA synthetase |
| ES2822830T3 (es) * | 2015-10-14 | 2021-05-05 | Bristol Myers Squibb Co | Antagonistas selectivos de NR2B |
-
2019
- 2019-10-16 MA MA53898A patent/MA53898B1/fr unknown
- 2019-10-16 IL IL282142A patent/IL282142B2/en unknown
- 2019-10-16 JP JP2021520981A patent/JP7093468B2/ja active Active
- 2019-10-16 HR HRP20230249TT patent/HRP20230249T1/hr unknown
- 2019-10-16 CR CR20210184A patent/CR20210184A/es unknown
- 2019-10-16 DK DK19786343.4T patent/DK3867244T3/da active
- 2019-10-16 US US16/654,030 patent/US11166958B2/en active Active
- 2019-10-16 MY MYPI2021001774A patent/MY205127A/en unknown
- 2019-10-16 MX MX2021004418A patent/MX2021004418A/es unknown
- 2019-10-16 AU AU2019362330A patent/AU2019362330B2/en active Active
- 2019-10-16 EA EA202191014A patent/EA202191014A1/ru unknown
- 2019-10-16 FI FIEP19786343.4T patent/FI3867244T3/fi active
- 2019-10-16 SG SG11202103806VA patent/SG11202103806VA/en unknown
- 2019-10-16 CN CN201980067936.7A patent/CN112888685B/zh active Active
- 2019-10-16 KR KR1020217014924A patent/KR102840105B1/ko active Active
- 2019-10-16 ES ES19786343T patent/ES2940184T3/es active Active
- 2019-10-16 PT PT197863434T patent/PT3867244T/pt unknown
- 2019-10-16 TW TW108137247A patent/TWI828779B/zh active
- 2019-10-16 NZ NZ773672A patent/NZ773672A/en unknown
- 2019-10-16 PL PL19786343.4T patent/PL3867244T3/pl unknown
- 2019-10-16 WO PCT/EP2019/078027 patent/WO2020079039A1/en not_active Ceased
- 2019-10-16 HU HUE19786343A patent/HUE061891T2/hu unknown
- 2019-10-16 BR BR112021004993-2A patent/BR112021004993A2/pt unknown
- 2019-10-16 LT LTEPPCT/EP2019/078027T patent/LT3867244T/lt unknown
- 2019-10-16 EP EP19786343.4A patent/EP3867244B1/en active Active
- 2019-10-16 CA CA3113308A patent/CA3113308A1/en active Pending
- 2019-10-16 AR ARP190102937A patent/AR116711A1/es unknown
- 2019-10-16 RS RS20230140A patent/RS63988B1/sr unknown
- 2019-10-16 PE PE2021000513A patent/PE20211278A1/es unknown
- 2019-10-16 UA UAA202102481A patent/UA128408C2/uk unknown
- 2019-10-16 SI SI201930465T patent/SI3867244T1/sl unknown
- 2019-10-16 JO JOP/2021/0075A patent/JOP20210075A1/ar unknown
-
2021
- 2021-04-07 CL CL2021000858A patent/CL2021000858A1/es unknown
- 2021-04-13 CO CONC2021/0004612A patent/CO2021004612A2/es unknown
- 2021-04-14 PH PH12021550834A patent/PH12021550834A1/en unknown
- 2021-04-14 SA SA521421756A patent/SA521421756B1/ar unknown
- 2021-04-16 DO DO2021000069A patent/DOP2021000069A/es unknown
- 2021-04-16 EC ECSENADI202127009A patent/ECSP21027009A/es unknown
- 2021-08-27 US US17/458,631 patent/US20210393644A1/en not_active Abandoned
-
2025
- 2025-01-15 US US19/022,358 patent/US20250345341A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284835A (en) | Pharmaceutical combination comprising tno155 and ribociclib | |
| IL285178A (en) | Compounds and uses thereof | |
| DK3784283T3 (da) | Cannabidiopræparater og anvendelser deraf | |
| DK3565550T3 (da) | Farmaceutiske sammensætninger omfattende meloxicam og rizatriptan | |
| DK3610005T3 (da) | Peptidligase og anvendelse deraf | |
| HUE053908T2 (hu) | Amid-szubsztituált piridiniltriazol-származékok és alkalmazásuk | |
| DK3307707T3 (da) | Halogensubstituerede phenoxyphenylamidiner og anvendelsen deraf som fungicider | |
| DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
| DK3786160T3 (da) | Pyridinderivater og terapeutiske anvendelser deraf som trpc6-inhibitorer | |
| DK3640207T3 (da) | Molekularsi scm-15, syntesefremgangsmåde dertil og anvendelse deraf | |
| DK3603620T3 (da) | Liposomsammensætning og farmaceutisk sammensætning | |
| DK3412660T3 (da) | Sulfonamidderivat og farmaceutisk sammensætning indeholdende samme | |
| HUE063120T2 (hu) | LRRC33-inhibitorok és alkalmazásuk | |
| HUE071358T2 (hu) | Benzolszulfonamid vegyületek és terápiás szerként való alkalmazásuk | |
| DK3514153T3 (da) | Pyrimidinforbindelse og farmaceutisk anvendelse deraf | |
| HUE066895T2 (hu) | Imidazolonilkinolin-származékok és terápiás alkalmazásuk | |
| EP3681509C0 (en) | WOUND REMEDY | |
| EP3781576C0 (en) | BORONIC ACID DERIVATIVES AND THEIR THERAPEUTIC USES | |
| DK3532459T3 (da) | Lsd1-hæmmere og medicinske anvendelser deraf | |
| DK3919498T6 (da) | Pyrrolopyrimidinderivat og anvendelse deraf | |
| DK3268374T3 (da) | Kv1.3-inhibitorer og deres medicinske anvendelse | |
| DK3568396T3 (da) | Hidtil ukendte amino-imidazopyridinderivater som janus kinase-inhibitorer og farmaceutisk anvendelse deraf | |
| IL284514A (en) | Halo-allylamine compounds and use thereof | |
| EP3856755A4 (en) | Terpinoid derivatives and uses thereof | |
| DK3615502T3 (da) | Terapeutiske forbindelser og fremgangsmåder |